secwatch.observer — SEC 8-K summary
======================================

Issuer:     Instil Bio, Inc. (TIL)
CIK:        0001789769
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001789769-23-000073
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Instil Bio stockholders approve reverse split authorization up to 1:30
----------------------------------------------------------------------

- Stockholders elected George Matcham and Neil Gibson as Class II directors; each received >85M votes for.
- Proposal 2 passed: board authorized to effect reverse stock split at ratio 1:10 to 1:30, effective before 2024 annual meeting.
- Proposal 3 approved: Deloitte & Touche LLP ratified as independent auditor for fiscal 2023 with 116.6M votes for.
- Approximately 89.97% of outstanding shares were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789769/000178976923000073/0001789769-23-000073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789769/000178976923000073/til-20230614.htm
  HTML page:      https://secwatch.observer/filing/0001789769-23-000073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer